Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Herminia, Esteban"'
Autor:
Jesús Troya, Pablo Ryan, Esteban Ribera, Daniel Podzamczer, Victor Hontañón, Jose Alberto Terrón, Vicente Boix, Santiago Moreno, Pilar Barrufet, Manuel Castaño, Ana Carrero, María José Galindo, Ignacio Suárez-Lozano, Hernando Knobel, Miguel Raffo, Javier Solís, María Yllescas, Herminia Esteban, Juan González-García, Juan Berenguer, Arkaitz Imaz, GESIDA-8314 Study Group
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0172184 (2017)
[This corrects the article DOI: 10.1371/journal.pone.0164455.].
Externí odkaz:
https://doaj.org/article/d2147a8b9c6f410685f11f4219507252
Autor:
Alfonso Cabello-Úbeda, Alicia González Baeza, Jesús Troya García, Sara de La Fuente Moral, María Novella Mena, Adriana Pinto Martínez, Rafael Micán, Miguel Górgolas, Guillermo Cuevas Tascón, Alberto Díaz de Santiago, José Sanz Morerno, David Rial Crestelo, Carmen Busca Arenzana, José Ignacio Bernardino Serna, Mariana Díaz Almirón, Joanna Cano, Herminia Esteban, Ignacio Pérez-Valero
Publikováno v:
Open Forum Infectious Diseases. 9
Background Although switching antiretroviral therapy (ART) in people with human immunodeficiency virus experiencing insomnia due to dolutegravir-related neurotoxicity is well founded upon evidence, there is a lack of proof in regard to the outcome of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::826ad64df6acd216ff73c105c22e8904
https://doi.org/10.1093/ofid/ofac345
https://doi.org/10.1093/ofid/ofac345
Autor:
Jesús Troya, Pablo Ryan, Esteban Ribera, Daniel Podzamczer, Victor Hontañón, Jose Alberto Terrón, Vicente Boix, Santiago Moreno, Pilar Barrufet, Manuel Castaño, Ana Carrero, María José Galindo, Ignacio Suárez-Lozano, Hernando Knobel, Miguel Raffo, Javier Solís, María Yllescas, Herminia Esteban, Juan González-García, Juan Berenguer, Arkaitz Imaz, GESIDA-8314 Study Group
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164455 (2016)
Based on data from clinical practice, we evaluated the effectiveness and safety of switching to abacavir/lamivudine plus rilpivirine (ABC/3TC+RPV) treatment in virologically suppressed HIV-1-infected patients.We performed a multicenter, non-controlle
Externí odkaz:
https://doaj.org/article/103689b34cd147e9826554a11e0335f9
Autor:
Ana, Carrero, Juan, Berenguer, Víctor, Hontañón, Josep M, Guardiola, Jordi, Navarro, Miguel A, von Wichmann, María J, Téllez, Carmen, Quereda, Ignacio, Santos, José, Sanz, María J, Galindo, José, Hernández-Quero, María A, Jiménez-Sousa, Leire, Pérez-Latorre, José M, Bellón, Salvador, Resino, Herminia, Esteban, Esteban, Martínez, Juan, González-García, H, Esteban
Publikováno v:
CLINICAL INFECTIOUS DISEASES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background Little is known about the effects of eradication of hepatitis C virus (HCV) on bone mineral density (BMD) and biomarkers of bone remodeling in human immunodeficiency virus (HIV)/HCV-coinfected patients. Methods We prospectively assessed st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5839bea1f1bdb69333b08d4b35735d2
https://doi.org/10.1093/cid/ciaa1396
https://doi.org/10.1093/cid/ciaa1396
Autor:
Blanca Xicoy, Josep-María Ribera, Pilar Miralles, Juan Berenguer, Rafael Rubio, Beatriz Mahillo, María-Eulalia Valencia, Eugenia Abella, Armando López-Guillermo, Ana Sureda, Mireia Morgades, José-Tomás Navarro, Herminia Esteban, GESIDA GELCAB Groups, Spain
Publikováno v:
Haematologica, Vol 92, Iss 2 (2007)
Background and Objectives Although doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) is considered the standard chemotherapy regimen for Hodgkin’s lymphoma (HL), information on the results of this therapy in human immunodeficiency (HIV)-re
Externí odkaz:
https://doaj.org/article/53fce3ec63db408e9f518474a04fa6e8
Autor:
Fernando Lozano, Eulalia Valencia, Concha Amador, Herminia Esteban, Antonio Ocampo, Ignacio Suarez, Miguel Ángel von Wichmann de Miguel, Rosario Palacios, José Ramón Blanco, Guillem Frontera, Melchor Riera
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 34:346-352
Resumen Introduccion El objetivo del estudio es validar los indicadores de calidad relevantes para la infeccion VIH de GESIDA, evaluando la fiabilidad, la factibilidad y la adhesion a los mismos. Metodos La fiabilidad fue evaluada mediante la reprodu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ee45ac0a19eea9807cb6cf3c64c0ffc
https://doi.org/10.1016/j.eimc.2015.09.003
https://doi.org/10.1016/j.eimc.2015.09.003
Autor:
Francisco Xavier Zamora, José María Bellón, María José Galindo, Ignacio Santos, Carmen Quereda, Juan Berenguer, Ana Carrero, José López-Aldeguer, Juan González-García, Herminia Esteban, José Sanz, Teresa Aldámiz-Echevarría, Josep M. Guardiola, María Jesús Téllez, Manel Crespo, Miguel A. Von Wichmann, Marisa Montes
Publikováno v:
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Objective: We assessed the effects of sustained viral response (SVR), after treating with interferon-ribavirin (IF-RB), on mortality, liver-related (LR) events (decompensation, hepatocellular carcinoma), HIV progression, and liver stiffness in HIV/he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9261c65c2ec716e46bf24a78a41f0d7
https://doi.org/10.1097/qai.0000000000000156
https://doi.org/10.1097/qai.0000000000000156
Autor:
Jose L. Casado Osorio, Herminia Esteban, Juan González-García, Enric Pedrol Clotet, Marta Mora Rillo, Ignacio Suárez-Lozano, Asuncion Hernando Jerez, Ana Royuela, Pere Domingo Pedrol, Elena Barquilla Diaz, Ramón Teira Cobo, Pablo Rivas González, José A. Pérez-Molina
Publikováno v:
Current HIV Research. 8:521-530
Objective: Currently, 12% of the Spanish population is foreign-born, and a third of newly diagnosed HIV-infected patients are immigrants. We determined whether being an immigrant was associated with a poorer response to antiretroviral treatment. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::accb524572097dfef2b854617caae6ba
https://doi.org/10.2174/157016210793499178
https://doi.org/10.2174/157016210793499178
Autor:
B. de la Fuente, Herminia Esteban, B. Mahillo, B. Moyano, R. Vicent, J. A. Cartón, O. Serrano, Rafael Rubio, M. Zarraga, María Antonia Sepúlveda, L. Serrano, J. Carmena, Antonio Ocampo, Esteban Ribera, Ana Mariño, Juan Flores, J Gonzalez-Garcia, Echevarría S, Victor Asensi, C. Minguez
Publikováno v:
HIV Medicine. 11:545-553
Background Atazanavir (ATV) boosted with ritonavir (ATV/r) is a potent, well-tolerated, once-daily protease inhibitor (PI). Few data are available on this agent as a treatment simplification option for patients taking other PIs. Objective The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11b0bef963ba46c0c414f501d980485f
https://doi.org/10.1111/j.1468-1293.2010.00827.x
https://doi.org/10.1111/j.1468-1293.2010.00827.x
Autor:
Sepúlveda-Crespo, Daniel1,2 (AUTHOR) crispu82@gmail.com, Volpi, Camilla1,3 (AUTHOR) camilla.volpi1@studenti.unimi.it, Amigot-Sánchez, Rafael1 (AUTHOR) rafael.amigot@isciii.es, Yélamos, María Belén4 (AUTHOR) mbyelamos@quim.ucm.es, Díez, Cristina2,5,6 (AUTHOR) jbb4@me.com, Gómez, Julián4 (AUTHOR) jgomezgu@ucm.es, Hontañón, Víctor7,8 (AUTHOR) victor.hontanon@gmail.com, Berenguer, Juan2,5,6 (AUTHOR) juangonzalezgar@gmail.com, González-García, Juan2,7,8 (AUTHOR), Martín-Escolano, Rubén1,2 (AUTHOR) r.martin@isciii.es, Resino, Salvador1,2 (AUTHOR) sresino@isciii.es, Martínez, Isidoro1,2 (AUTHOR) sresino@isciii.es
Publikováno v:
Pharmaceuticals (14248247). Sep2024, Vol. 17 Issue 9, p1152. 15p.